HIV research has encountered quite a few setbacks, especially with attempts to create an HIV vaccination. But topical microbicides made from glycerol monolaurate, commonly found in some foods and cosmetics, are showing some promise. What mechanisms of microbicides may help successfully prevent infection, including HIV and other sexually transmitted infections? Dr. Patrick Schlievert, professor of microbiology and immunology at the University of Minnesota Medical School, explains the exciting potential of topical microbicides for preventing the transmission of sexually transmitted infections and HIV. How soon might one of these topical microbicides be available, if they are further proved to have efficacy? Dr. Lee Freedman hosts.
Are Microbicides the Next Breakthrough in HIV?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
HIV research has encountered quite a few setbacks, especially with attempts to create an HIV vaccination. But topical microbicides made from glycerol monolaurate, commonly found in some foods and cosmetics, are showing some promise. What mechanisms of microbicides may help successfully prevent infection, including HIV and other sexually transmitted infections? Dr. Patrick Schlievert, professor of microbiology and immunology at the University of Minnesota Medical School, explains the exciting potential of topical microbicides for preventing the transmission of sexually transmitted infections and HIV. How soon might one of these topical microbicides be available, if they are further proved to have efficacy? Dr. Lee Freedman hosts.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
M3: Managing the Cardiometabolic Risk in MASH
Beyond Longevity: Discussing TAVR Durability for Women & Patients With Small Annuli
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
Level Up Your Skills: Tailoring Management of HF
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
Impact of Barostim on Heart Failure Hospitalization
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?